Peak6 Investments LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 14, 2024	BUY	$171.37 - $283.23 $257,055 - $424,845	1,500 Added 78.95%	3,400 $907,000
Q4 2023 Feb 13, 2024	BUY	$120.4 - $237.13 $228,760 - $450,547	1,900 New	1,900 $439,000
Q2 2023 Aug 11, 2023	BUY	$203.88 - $312.0 $224,268 - $343,200	1,100 New	1,100 $254,000
Q4 2020 Feb 12, 2021	SELL	$110.06 - $133.7 $825,450 - $1 Million	-7,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$99.78 - $124.21 $748,350 - $931,575	7,500 New	7,500 $890,000
Q4 2018 Feb 13, 2019	SELL	$94.77 - $215.54 $142,155 - $323,310	-1,500 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$207.3 - $300.31 $310,950 - $450,465	1,500 New	1,500 $321,000

298

22M

757K

370K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.63B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.